Federal contract award
75F40125F19007
LABOR HOUR AWARD CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) OFFICE OF NEW DRUGS (OND) - HEALTH SCIENCE SUPPORT NOTICE TO PROCEED WAS ISSUED ON 06/17/2025 EFFECTIVE 06/19/2025. CONTRACTING OFFICER'S REPRESENTATIVE (COR) SHILA NDEH
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541611 — Administrative Management and General Management Consulting Services |
| PSC | R499 — Other Professional Services |
| Parent award / vehicle | 75F40123D00021 |
| Set-aside | Not reported |
| Pricing type | LABOR HOURS |
| Obligations | $7.3M |
| Current contract value | $7.3M |
| Potential contract value / ceiling | $13.0M |
| Start date | Jun 25, 2025 |
| Current end date | Nov 14, 2026 |
| Potential end date | Nov 14, 2027 |
| Latest award activity | May 15, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 6 of 6 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 15, 2026 | P00005 | $348.0K | LABOR HOUR AWARD CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) OFFICE OF NEW DRUGS (OND) - HEALTH SCIENCE SUPPORT CONTRACTING OFFICER'S REPRESENTATIVE (COR) SHILA NDEH SHILA.NDEH@FDA.HHS.GOV TEL: 301-796-8347 CONTRACTING SPECIALIST |
| Dec 2, 2025 | P00004 | $5.1M | LABOR HOUR AWARD CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) OFFICE OF NEW DRUGS (OND) - HEALTH SCIENCE SUPPORT CONTRACTING OFFICER'S REPRESENTATIVE (COR) SHILA NDEH SHILA.NDEH@FDA.HHS.GOV TEL: 301-796-8347 CONTRACTING SPECIALIST |
| Nov 12, 2025 | P00003 | $0 | LABOR HOUR AWARD CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) OFFICE OF NEW DRUGS (OND) - HEALTH SCIENCE SUPPORT CONTRACTING OFFICER'S REPRESENTATIVE (COR) SHILA NDEH SHILA.NDEH@FDA.HHS.GOV TEL: 301-796-8347 CONTRACTING SPECIALIST |
| Oct 30, 2025 | P00002 | $0 | LABOR HOUR AWARD CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) OFFICE OF NEW DRUGS (OND) - HEALTH SCIENCE SUPPORT CONTRACTING OFFICER'S REPRESENTATIVE (COR) SHILA NDEH SHILA.NDEH@FDA.HHS.GOV TEL: 301-796-8347 CONTRACTING SPECIALIST |
| Oct 9, 2025 | P00001 | $0 | LABOR HOUR AWARD CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) OFFICE OF NEW DRUGS (OND) - HEALTH SCIENCE SUPPORT CONTRACTING OFFICER'S REPRESENTATIVE (COR) SHILA NDEH SHILA.NDEH@FDA.HHS.GOV TEL: 301-796-8347 CONTRACTING SPECIALIST |
| Jun 25, 2025 | 0 | $1.8M | LABOR HOUR AWARD CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) OFFICE OF NEW DRUGS (OND) - HEALTH SCIENCE SUPPORT NOTICE TO PROCEED WAS ISSUED ON 06/17/2025 EFFECTIVE 06/19/2025. CONTRACTING OFFICER'S REPRESENTATIVE (COR) SHILA NDEH |
Estimated positioning window
Nov 14, 2026 – May 14, 2027
65/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 65/100. Available recorded signals: 60 points.
- Contract end 2027-11-14 (378 days from calculation)
- +25 points
- 173 historical awards in this buyer and category group
- +15 points
- 6 recorded award transactions
- +10 points
- Latest award action: 2026-05-15
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.